Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H. pylori Eradication to Prevent Gastric Cancer in Subjects With Family History
NCT01678027Phase 3Active, not recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Nov 2004
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole, amoxicillin, clarithromycin in Helicobacter pylori infection, gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Nov 2004; status: active, not recruiting.
02
Drugs
lansoprazoleamoxicillinclarithromycin
03
Conditions
Helicobacter pylori infectiongastric cancer (GC)
Beyond the preview
Go deeper on NCT01678027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01678027.